• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov11
Matinas Biopharma released FY2025 9 Months Earnings on November 10, 2025 (EST) with actual revenue of USD 0 and EPS of USD -1.3565
04:00
Matinas Biopharma released FY2025 Q3 earnings on November 10 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.3955 (forecast USD --)
04:00
Aug15
Matinas Biopharma released FY2025 Semi-Annual earnings on August 14, 2025 (EST) with actual revenue of USD 0 and EPS of USD -1.3565
03:00
Matinas Biopharma released FY2025 Q2 earnings on August 14, 2025 (EST), with actual revenue of USD 0 and EPS of USD -1.031
03:00
May16
Matinas Biopharma released FY2025 Q1 earnings on May 15, 2025 (EST) with actual revenue of USD 0 and EPS of USD -0.3255
03:00
May2
Matinas Biopharma Holdings Amends Key Executives' Employment Contracts
21:16

Schedules & Filings

Schedules
Filings
Nov10
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -2.15 M, EPS -0.3955

Aug14
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -5.245 M, EPS -1.031

May15
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -1.656 M, EPS -0.3255

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
TGL
18.320
+171.09%
+11.562
SMX
292.220
+107.25%
+151.220
WHLR
5.420
+67.28%
+2.180
DBRG
13.930
+43.31%
+4.190
IRBT
4.216
+39.16%
+1.185
TDIC
0.3804
+35.47%
+0.099
LICN
3.869
+32.05%
+0.939
ALMS
10.865
+30.90%
+2.565
PRAX
247.970
+30.53%
+58.040
TORO
5.390
+30.51%
+1.260
View More